Вопросы современной педиатрии (Jan 2011)

EFFICACY AND SAFETY OF IBANDRONIC ACID ADMINISTERED INTRAVENOUSLY TO JUVENILE ARTHRITIS PATIENTS WITH SEVERE SYSTEM OSTEOPOROSIS

  • R.V. Denisova,
  • E.I. Alexeeva,
  • V.G. Pinelis,
  • M.I. Bakanov,
  • S.I. Valieva,
  • T.M. Bzarova,
  • K.B. Isaeva,
  • S.Yu. Morev,
  • G.V. Kuznetsova

Journal volume & issue
Vol. 10, no. 6

Abstract

Read online

The article is dedicated to study of efficacy and safety of ibandronic acid administered intravenously to 25 patients suffering from juvenile arthritis and system osteoporosis. It was concluded that administration of 3 mg of ibandronate every 3 months during 76 weeks increase CTX, which indicates improvement of bone metabolism. During the treatment no subsequent vertebrae fractures have been registered. Increase in bone mass during the ibandronate therapy has been sufficient to allow endoprosthetic hip replacement in 7 patients.Key words: child, juvenile arthritis, osteoporosis, treatment, biophosphates, ibandronic acid. (Voprosy sovremennoi pediatrii — Current Pediatrics. — 2011; 10 (6): 83–88)

Keywords